Cancer drug has right to patent, Novartis tells Supreme Court
The final hearings have started at the Supreme Court regarding Swiss drug-major Novartis' blood cancer drug Glivec.
Publication Date:
11/08/2011
The final hearings have started at the Supreme Court regarding Swiss drug-major Novartis' blood cancer drug Glivec.